Emily Sieg, MD
Neurological Surgery · Louisville, KYNPI 1285926857
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,300 of the $9,015 with a category attached, or 69.9%. Medical Device Business Services, Inc. accounts for 69.9% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $4,403 and has fallen 84.4% since, to $687 in 2025.
Across 32 payments — averaging $281.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$6K
- Stryker$1K
- Medtronic$569
- Johnson & Johnson$219
- Kerecis Limited$197
- Irras USA, Inc.$140
- plus $503 from 9 others
Across 12 payments — averaging $5500.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$65K
- Stryker$1K
What the payments were for
- Consulting fees$6,30070%
- Travel & lodging$8519%
- Food & beverage$1,86421%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 2 | $6,300 |
| Stryker | 9 | $1,087 |
| Medtronic(2 entities) | 7 | $569 |
| Johnson & Johnson | 2 | $219 |
| Kerecis Limited | 1 | $197 |
| Irras USA, Inc. | 1 | $140 |
| Alphatec Spine, Inc | 1 | $134 |
| Globus Medical | 1 | $107 |
| Boston Scientific | 1 | $98 |
| ZOLL Medical Corporation | 1 | $59 |
| AbbVie | 2 | $36 |
| Sanara Medtech Inc. | 1 | $19 |
| Merz Pharmaceuticals, LLC | 1 | $19 |
| Amgen | 1 | $17 |
| Zimmer Biomet | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MATRIXNEURO$6,300
- SYNTHECEL$6,300
- Kerecis SurgiClose$789
- TRITANIUM$752
- Kerecis GraftGuide$197
- STEALTHSTATION S8 PLATFORM$169
- Vivigen MIS Delivery System$159
- LATERAL ACCESS SPINAL SYSTEM$141
- GENERAL K2M PRODUCT DISCUSSION$141
- MAGNIFUSE BONE GRAFT$129
- Duet$120
- FORTIFY$107
How this compares
$9,015 in reported general payments places this provider in the 70th percentile of 99 neurological surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 17 | $156 |
| Cyclobenzaprine Hcl | 16 | $46 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Louisville
- Tom YaoLouisville$405K
- Joseph NeimatLouisville$196K
- Maria KoutourousiouLouisville$189K
- Shervin DashtiLouisville$146K
- Shawn AdamsLouisville$73K
- Nathaniel ToopLouisville$56K
- Thomas AltstadtLouisville$36K
- Brian WilliamsLouisville$33K
- Ajmal ZemmarLouisville$32K
- Redi RahmaniLouisville$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.